ScholarIQanswers from OpenAlex
European Society for Medical Oncology
FunderResearch funding and supported work
European Society for Medical Oncology is a funder indexed in ScholarIQ from OpenAlex.
What is known about European Society for Medical Oncology?
ScholarIQrecord summary
Professional organisation
How many works does European Society for Medical Oncology have?
ScholarIQindexed works
European Society for Medical Oncology has 2,709 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for European Society for Medical Oncology?
ScholarIQopenalex
The OpenAlex for European Society for Medical Oncology is on the source record.
What is the ROR of European Society for Medical Oncology?
ScholarIQror
The ROR for European Society for Medical Oncology is on the source record.
What are the most-cited papers on European Society for Medical Oncology?
ScholarIQmost cited works
Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote, Whitney A. Spannuth Graybill, Domenica Lorusso, Colleen McCormick, Gilles Freyer, Floor Backes, Florian Heitz, Andrés Redondo, Richard G. Moore, Christof Vulsteke, Roisin E. O’Cearbhaill, Izabela A. Malinowska, Luda Shtessel, Natalie Compton, Mansoor R. Mirza, Bradley J. Monk
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome
Laura Mezquita, Maria Jové, Ernest Nadal, Maria Kfoury, Teresa Morán, Charles Ricordel, Marion Dhooge, Camille Tlemsani, H. Léna, Àlex Teulé, Jose-Valero Álvarez, Judith Raimbourg, Sandrine Hiret, Ludovic Lacroix, Mireia Menéndez, Juana Saldaña, Joan Brunet, P. Lianes, Isabelle Coupier, Édouard Auclin, Gonzalo Recondo, Luc Friboulet, Julien Adam, Emma Green, David Planchard, Thierry Frébourg, Gabriel Capellá, Étienne Rouleau, Conxi Lázaro, Olivier Caron, Benjamin Besse
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Giorgio Valabrega, Bhavana Pothuri, Ana Oaknin, Whitney S. Graybill, Ana Beatriz Sánchez, Colleen McCormick, Jean‐François Baurain, Anna V. Tinker, Hannelore Denys, Roisin E. O’Cearbhaill, Sakari Hietanen, Richard G. Moore, Anja Ør Knudsen, Thibault de La Motte Rouge, Florian Heitz, Tally Levy, Whitney York, Divya Gupta, Bradley J. Monk, Antonio González-Martı́n